Condition (MeSH)
von Willebrand Disease, Type 2
ClinicalTrials.gov lists 2 trials for von Willebrand Disease, Type 2 or a narrower condition beneath it. Hemab ApS has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with von Willebrand Disease, Type 2 itself; the rest are tagged with a narrower condition beneath it.
When did von Willebrand Disease, Type 2 trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2024 | 1 |
| 2019 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are von Willebrand Disease, Type 2 trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 1 |
| Observational | 1 |
How many von Willebrand Disease, Type 2 trials are recruiting? (2)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most von Willebrand Disease, Type 2 trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Hemab ApS | 1 |
Which publications cover von Willebrand Disease, Type 2? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. | Blood advances | 2022 | Yes |
| Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease? | PloS one | 2018 | Yes |
| von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy. | Hematology. American Society of Hematology. Education Program | 2013 | Yes |
| Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patients. | Journal of thrombosis and haemostasis : JTH | 2012 | Yes |
| Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease. | American journal of hematology | 2020 | No |
Showing 5 of 7 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Von Willebrand disease type 2 | Point prevalence | 1-9 / 1 000 000 | Worldwide | Not stated | Exact |
| Von Willebrand disease type 2 | Point prevalence | 1-9 / 1 000 000 | Worldwide | Not stated | Unspecified |
| Von Willebrand disease type 2 | Point prevalence | 1-9 / 1 000 000 | Worldwide | Not stated | Exact |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Von Willebrand disease type 2 | 166081 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Von Willebrand disease type 2 | 166081 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.